Skip to content
OpenCapital
Get started

Avanos Medical AVNS Radiofrequency ablation — Net Sales

Other product segments

Enteral feeding
$84.6M+13.6%
Neonate solutions
$39.4M+48.1%
Surgical pain and recovery
$21.8M-11.0%

Similar metrics at other companies

AtriCure logo
ATRCMinimally invasive ablation — Revenue from Contract with Customer, Excluding Assessed Tax
$8.3M-20.9%
AtriCure logo
ATRCOpen ablation — Revenue from Contract with Customer, Excluding Assessed Tax
$48.6M+14.9%
Boston Scientific logo
BSXElectrophysiology — Net Sales
$905M+24.0%
Boston Scientific logo
BSXCardiac Rhythm Management — Net Sales
$578M0.0%
Baxter International logo
BAXAdvanced Surgery — Net Sales
$304M+13.4%
Boston Scientific logo
BSXInterventional Cardiology & Vascular Therapies — Net Sales
$1.16B+10.5%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's radiofrequency ablation — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's radiofrequency ablation — net sales?
Avanos Medical (AVNS) reported radiofrequency ablation — net sales of $34.5M in Q1 2026.
How has Avanos Medical's radiofrequency ablation — net sales changed year-over-year?
Avanos Medical's radiofrequency ablation — net sales increased by 8.8% year-over-year, from $31.7M to $34.5M.
What is the long-term trend for Avanos Medical's radiofrequency ablation — net sales?
Over 2 years (2023 to 2025), Avanos Medical's radiofrequency ablation — net sales has grown at a 12.5% compound annual growth rate (CAGR), from $109.8M to $139M.
What does radiofrequency ablation — net sales mean?
This metric represents the total revenue generated from the sale of radiofrequency ablation medical devices and related procedural technologies. It reflects the market adoption and commercial performance of the company's interventional pain management product portfolio. Growth in this area indicates successful penetration into clinical settings for minimally invasive pain relief solutions.